BURLINGTON, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in June.
JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at the Marriott Marquis in New York City. The company’s presentation is scheduled at 3:00 PM ET.
David Roberts, President, will present at the Sidoti Small Cap Virtual Conference on Thursday, June 15, 2023 at 1:45 PM ET.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$86.28 |
| Daily Change: | 1.61 1.90 |
| Daily Volume: | 182,235 |
| Market Cap: | US$1.940B |
April 01, 2025 February 27, 2025 December 16, 2024 October 31, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
